Global incidents of counterfeit pharmaceuticals and fake drugs via Internet

ASPA and Messe Frankfurt India to are bringing experts to discuss ideas for securing the pharmaceutical supply chain from counterfeits at a live panel discussion on 11 June 2021.

Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of Covid-19. What happens when the ray of hope – vaccines, become vulnerable to the scourge of counterfeiting?

Amid the onslaught of the second wave of Covid-19, the healthcare sector is under heavy pressure owing to the rising cases across different states. Moreover, the growing demand for medicines, protective gear and other pharmaceutical equipment has given rise to counterfeiting, tampering and diversion of these life-saving products, thus putting the health of millions at risk around the globe. This just proves how important it is for pharmaceutical companies are fully compliant with FDA regulations, and they can hire FDA regulatory consulting agencies to achieve that.

The Covid-19 vaccines are also prone to counterfeiting, putting the global pharmaceutical fraternity on red alert. To address this menace and to introduce greater authenticity in the pharmaceutical supply chain, ASPA (Authentication Solution Providers’ Association) and Messe Frankfurt India are all set to host a high-profile panel discussion on 11 June 2021.

Panelists will explain life-threatening practice of pharma counterfeiting

As a part of ‘The Authentication Forum,’ the webinar will address the theme of “Protecting lives & securing the pharmaceutical supply chain during Covid-19.” Senior leaders, regulatory officials and international experts will attend and share their perspective on the burning issue and discuss collective measures to eradicate the unethical and life-threatening practice of pharmaceutical counterfeiting. The group of panelists will include –

  • Dr Praveen Gedam, Additional CEO, National Health Authority, Government of India
  • Prashant K. Gupta, Country Head Sales, Shriram Veritech Solutions Pvt. Ltd.
  • Girish Pai, Chief Business Officer, Pharmasecure
  • S. Swaminathan, Chief Executive Officer, GS1 India
  • Rajiv Joshi, Partner, Forensic & Integrity Services, Ernst & Young LLP (Moderator)

The webinar will be supported by the authentication partners and solutions providers including Shriram Veritech, PharmaSecure and Holographic Security Marking Systems.

Elaborating on the aim to host the webinar, Raj Manek, executive director and board member, Messe Frankfurt Asia Holdings, said, “The increasing penetration of spurious pharmaceutical products has escalated into a major issue across the world. Many countries are still dealing with the pandemic and under such [a] critical scenario it is crucial to find solutions to combat counterfeiting and introduce a new degree of authenticity in the pharmaceutical supply chain.”

Commenting further, Nakul Pasricha, president, ASPA, said, “The COVID-19 pandemic has overwhelmed India’s healthcare system. There are various issues which need to be addressed immediately, including eliminating sub-standard and falsified medicines from the system as well as ensuring availability of affordable and quality health services. As an association, ASPA is committed to build the authentication eco-systems in the country and these webinars are our way to contribute to fighting this menace by bringing this issue into the limelight at all Industry and government forums.”

ASPA is the only body in India representing authentication and traceability solutions providers. The association aims to educate brand owners, government authorities and consumers about the importance of fighting counterfeiting and how authentication solutions can help in this regard. In partnership with Messe Frankfurt India, ASPA is determined to take this initiative forward to foster a well-authenticated and well-secured pharmaceutical supply chain.

According to a report released by the World Health Organisation, 1 out of 10 medicines sold in low and middle-income countries, were tested as substandard and falsified. It is high time for the industry to develop a stronger framework for testing and authentication of pharmaceutical products. “We hope that uniting the industry players through ‘The Authentication Forum’ webinar will aid in deriving resolute measures to resolve the counterfeiting menace that has been ailing the industry since ages.” added Manek.

Messe Frankfurt has been actively involved in addressing the counterfeiting issues across industries including automotive, pharmaceutical and FMCG. Through conferences like Pharmasafe India, Medical Device Innovation Summit (MDIS) [now known as MedTech Innovation Forum] along with The Authentication Forum, Messe Frankfurt India aims to draw attention to the factors concerning counterfeiting of medicines and effective initiatives, regulations, and policies required to curb this menace.

We anticipate lively discussion and interaction at PACK.Nxt. Although to some, our topics sound futuristic, a recent eMailer to brand owners suggests, that they are not! As was heard at the recent drupa promotion conferences, ‘The Future is Now.’ It’s been a while since we had some sensible technology discussion with take home and actionable value. Why not take the opportunity at your doorstep to be a part of it? See you on 18 January 2024 at the Lalit Hotel in Mumbai!

At the PACK.Nxt Conference in Mumbai at the Lalit Hotel on 18 January, leading brand owners and technology suppliers will discuss Brand Protection, Authentication, Supply Chain Tracking, Customer Engagement, the Extended User Responsibility Regulations, and Sustainable and Recyclable Packaging Structures. For more information and registration click here.

Packaging South Asia — resilient, growing and impactful — daily, monthly — always responsive

The multi-channel B2B in print and digital 17-year-old platform matches the industry’s growth trajectory. The Indian, South Asian, Southeast Asian, and Middle East packaging industries are looking beyond the resilience of the past three years. They are resuming capacity expansion and diversification, with high technology and automation in new plants and projects.

As we present our 2024 publishing plan, India’s real GDP growth for the financial year ending 31 March 2024 will exceed 6%. The packaging industry growth will match the GDP growth in volume terms and surpass it by at least 3% in terms of nominal growth allowing for price inflation in energy, raw materials, consumables, and capital equipment.

The capacity for flexible film manufacturing in India increased by 45% over the past four years. With orders in place, we expect another 20% capacity addition in 2024 and 2025. Capacities in monocartons, corrugation, aseptic liquid packaging, and labels are growing similarly. As the consumption story returns over the next six months, we expect demand to return and exceed the growth trajectory of previous years. The numbers are positive for most of the economies in the region – and as shown by our analytics, our platform increasingly reaches and influences these.

For responsible and sustainable packaging, with its attendant regulations and compliances, there is significant headroom to grow in India and the region. Our coverage includes the entire packaging supply chain – from concept to shelf and to waste collection, sorting, and recycling.

We target brand owners, product managers, raw material suppliers, packaging designers and converters, and recyclers. This is a large and complex canvas – the only thing that can work is your agile thinking and innovation together with our continuous learning and persistence.

The coming year looks to be an up year in this region, and this is the right time to plan your participation and marketing communication – in our rich and highly targeted business platform with human resources on the ground. Share your thoughts and plans to inspire and mobilize our editorial and advertising teams!

For editorial — for advertisement and for subscriptions

– Naresh Khanna (25 October 2023)

Subscribe Now
unnamed 1


Subscribe to our Newsletter

Previous articleMespack’s turnkey and highly customized solutions at PMEC 2023
Next articleUnderstanding the application of powder filling
Naresh Khanna
Editor of Indian Printer and Publisher since 1979 and Packaging South Asia since 2007. Trained as an offset printer and IBM 360 computer programmer. Active in the movement to implement Indian scripts for computer-aided typesetting. Worked as a consultant and trainer to the Indian print and newspaper industry. Visiting faculty of IDC at IIT Powai in the 1990s. Also founder of IPP Services, Training and Research and has worked as its principal industry researcher since 1999. Author of book: Miracle of Indian Democracy. Elected vice-president of the International Packaging Press Organization in May 2023.


Please enter your comment!
Please enter your name here